Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Grothey

Showing results (61-70 of 303) with videos related to

Pageof 31
Sort By:
Nature Reviews. Gastroenterology & Hepatology|June 3, 2016
Therapy: Colorectal cancer: how to teach an old drug new tricksAxel Grothey, Lee M Ellis
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapiesAxel Grothey, Lee M Ellis
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Adolescent and young adult colorectal cancerJoleen M Hubbard, Axel Grothey
JAMA Oncology|June 9, 2016
Adjuvant Therapy for Colon Cancer: Small Steps Toward Precision MedicineAxel Grothey, Daniel J Sargent
Lancet (London, England)|May 7, 2013
Regorafenib for metastatic colorectal cancer - Authors' replyEric Van Cutsem, Axel Grothey
The Lancet. Oncology|September 30, 2017
Continued disappointments with targeted agents in first-line therapy of advanced gastric cancersDaniel H Ahn, Axel Grothey
Cancer Journal (Sudbury, Mass.)|June 25, 2016
Chemotherapy MaintenancePashtoon Murtaza Kasi, Axel Grothey
Journal of the National Cancer Institute|February 11, 2014
The challenge to optimize medical therapy for advanced colorectal cancerJoleen M Hubbard, Axel Grothey
Drugs|June 3, 2017
Napabucasin: An Update on the First-in-Class Cancer Stemness InhibitorJoleen M Hubbard, Axel Grothey
Biologics : Targets & Therapy|August 27, 2009
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumabGeorge P Kim, Axel Grothey
Pageof 31

Showing results (61-70 of 303) with videos related to

Sort By:
Pageof 31
Nature Reviews. Gastroenterology & Hepatology|June 3, 2016
Therapy: Colorectal cancer: how to teach an old drug new tricksAxel Grothey, Lee M Ellis
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapiesAxel Grothey, Lee M Ellis
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Adolescent and young adult colorectal cancerJoleen M Hubbard, Axel Grothey
JAMA Oncology|June 9, 2016
Adjuvant Therapy for Colon Cancer: Small Steps Toward Precision MedicineAxel Grothey, Daniel J Sargent
Lancet (London, England)|May 7, 2013
Regorafenib for metastatic colorectal cancer - Authors' replyEric Van Cutsem, Axel Grothey
The Lancet. Oncology|September 30, 2017
Continued disappointments with targeted agents in first-line therapy of advanced gastric cancersDaniel H Ahn, Axel Grothey
Cancer Journal (Sudbury, Mass.)|June 25, 2016
Chemotherapy MaintenancePashtoon Murtaza Kasi, Axel Grothey
Journal of the National Cancer Institute|February 11, 2014
The challenge to optimize medical therapy for advanced colorectal cancerJoleen M Hubbard, Axel Grothey
Drugs|June 3, 2017
Napabucasin: An Update on the First-in-Class Cancer Stemness InhibitorJoleen M Hubbard, Axel Grothey
Biologics : Targets & Therapy|August 27, 2009
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumabGeorge P Kim, Axel Grothey
Pageof 31